Andrew Barnell, CEO and co-founder of Geneoscopy, a VC-backed biotech company that makes an FDA-approved colorectal screening test, hopes the new administration will deliver on promises to cut down on the bureaucracy that he says is a hindrance to bringing products to market. “If unnecessary red tape is eliminated from that pathway, I think it only spurs investment in the space,” he says…
